+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032- Product Image
New

In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904896
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in-vitro diagnostics quality control market is evolving rapidly, as laboratory leadership responds to heightened scrutiny, regulatory changes, and the increasing complexity of clinical workflows. Senior executives are tasked with steering organizations toward best-in-class quality management frameworks to ensure diagnostic reliability and meet cross-functional expectations.

Market Snapshot: In-Vitro Diagnostics Quality Control Market

The in-vitro diagnostics quality control market demonstrates robust, sustained growth with a consistent compound annual growth rate (CAGR) that reflects strong sector confidence. With year-over-year expansion, laboratory procurement and operations leaders are navigating an accelerated push for interoperability, process automation, and end-to-end traceability. In both centralized and distributed lab environments, rising regulatory expectations and continual increases in test volume have placed quality assurance at the fore. The market continues to scale as networks invest in advanced diagnostic technologies and system integration to support broad clinical requirements and dynamic healthcare demands.

Scope & Segmentation

  • Product Types: Includes a range of analyzers, instruments, and platforms designed to accommodate both high-throughput and semi-automated lab workflows. Encompasses liquid and lyophilized control materials, with each type presenting unique advantages for stability and workflow efficiency in rigorous quality processes.
  • Technology Modalities: Covers modalities such as clinical chemistry, hematology, colorimetric and turbidimetric assays, automated cell counting, and flow cytometry. Also incorporates immunoassay approaches like chemiluminescence, ELISA, fluorescence, along with fully automated microbiology and molecular diagnostics, spanning PCR and next-generation sequencing.
  • Applications: Addresses uses including cardiac marker detection, genetic and prenatal screening, point-of-care and infectious disease testing, as well as oncology and toxicology. Specialized assays, such as those for minimal residual disease and drugs of abuse, serve both rapid response and complex laboratory environments.
  • End Users: Considers stakeholders such as blood banks, hospital labs, independent and reference laboratories, clinics, and research institutes. Variations in technology preference, adoption rates, and compliance needs across these segments inform purchasing and standardization decisions.
  • Regions: Explores market dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific. Each region exhibits unique procurement approaches, compliance drivers, and modernization speeds that impact quality priorities and regulatory alignment.

Key Takeaways for Senior Decision-Makers

  • Strategic alignment across instrument selection, reagent management, and digital workflow integration minimizes variability and sustains robust audit readiness.
  • Integrated automation and data platforms allow traceable, machine-readable documentation, simplifying identification of deviations and accelerating corrective actions.
  • Documented quality systems and risk-based controls are crucial as external stakeholder expectations intensify, ensuring ongoing compliance and fostering a culture of continual improvement.
  • Segment-focused quality strategies and thorough validation of consumables help optimize specialty workflows in areas like genetics, cardiology, oncology, and infectious disease testing.
  • Forging effective vendor relationships—blending instrumentation, standardized reagents, and dedicated quality management software—reduces process complexity and increases audit preparedness.
  • Targeted staff training and effective change management are central to harnessing the operational benefits offered by automation and data-driven technologies within the laboratory quality environment.

Assessing Tariff Policy Impact

Recent changes in United States tariff regulations have introduced both financial and operational challenges for diagnostic laboratories dependent on international sources for key instruments and consumables. Procurement functions now need to reassess supplier portfolios, strengthen supply chain resilience, and enhance substitute product validation. During supplier transitions, laboratories should focus on meticulous change-control documentation and uphold rigorous quality validation to meet regulatory expectations and maintain clinician trust. Additionally, the emergence of new software licensing requirements and decisions related to local versus cloud-based hosting continue to shape procurement and risk management strategies.

Methodology & Data Sources

This research leverages a mixed-methods approach, drawing from structured interviews and workshops with laboratory directors, technical experts, and procurement professionals. Qualitative findings are triangulated against regulatory publications, scientific literature, technical specifications, and leading industry standards, ensuring accurate perspective and methodological integrity.

Why This Report Matters

  • Delivers actionable guidance for executives to enhance procurement, risk management, and modernization initiatives, supporting organizational resilience across laboratory networks.
  • Facilitates benchmarking and vendor selection by dissecting operational and quality drivers across geographical and technical segments.
  • Equips senior leaders with clarity on compliance priorities, ensuring laboratories maintain reputation and success in dynamic diagnostic environments.

Conclusion

The in-vitro diagnostics quality control market is redefining laboratory operational standards. Leaders who champion standardization, invest in digital transformation, and prioritize partnership with suppliers will drive lasting value and reliability for their organizations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. In-Vitro Diagnostics Quality Control Market, by Product Type
8.1. Analyzers & Instruments
8.1.1. Automated Systems
8.1.2. Semi-Automated Systems
8.2. Control Materials
8.3. QC Reagents
8.3.1. Liquid Controls
8.3.2. Lyophilized Controls
8.4. Software Solutions
8.4.1. Data Management Systems
8.4.2. LIMS
8.4.3. QC Software
9. In-Vitro Diagnostics Quality Control Market, by Technology
9.1. Clinical Chemistry
9.1.1. Colorimetric
9.1.2. Turbidimetric
9.2. Hematology
9.2.1. Automated Cell Counters
9.2.2. Flow Cytometry
9.3. Immunoassay
9.3.1. Chemiluminescence Immunoassay
9.3.2. ELISA
9.3.3. Fluorescence Immunoassay
9.4. Microbiology
9.4.1. Culture
9.4.2. PCR
9.5. Molecular Diagnostics
9.5.1. Next-Generation Sequencing
9.5.2. PCR
10. In-Vitro Diagnostics Quality Control Market, by Application
10.1. Cardiology
10.1.1. Cardiac Marker Testing
10.1.2. Point-Of-Care Testing
10.2. Genetic Testing
10.2.1. Carrier Screening
10.2.2. Prenatal Testing
10.3. Infectious Disease Testing
10.3.1. Bacterial Detection
10.3.2. Viral Detection
10.4. Oncology
10.4.1. Minimal Residual Disease
10.4.2. Tumor Marker Testing
10.5. Toxicology
10.5.1. Drugs Of Abuse
10.5.2. Therapeutic Drug Monitoring
11. In-Vitro Diagnostics Quality Control Market, by End User
11.1. Blood Banks
11.1.1. National Blood Banks
11.1.2. Regional Blood Banks
11.2. Diagnostic Laboratories
11.2.1. Hospital-Based Laboratories
11.2.2. Independent Laboratories
11.3. Hospitals & Clinics
11.3.1. Clinic Laboratories
11.3.2. Reference Laboratories
11.4. Research Institutes
11.4.1. Academic Institutes
11.4.2. Private Research Laboratories
12. In-Vitro Diagnostics Quality Control Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. In-Vitro Diagnostics Quality Control Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. In-Vitro Diagnostics Quality Control Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States In-Vitro Diagnostics Quality Control Market
16. China In-Vitro Diagnostics Quality Control Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Becton, Dickinson and Company
17.7. Bio-Rad Laboratories, Inc.
17.8. Danaher Corporation
17.9. Grifols, S.A.
17.10. Microbix Biosystems Inc.
17.11. QuidelOrtho Corporation
17.12. Randox Laboratories Ltd.
17.13. Roche Holding AG
17.14. Seracare Life Sciences, Inc.
17.15. Siemens Healthineers AG
17.16. Sun Diagnostics, LLC
17.17. Sysmex Corporation
17.18. Thermo Fisher Scientific Inc.
17.19. Werfen, S.A.
17.20. ZeptoMetrix LLC
List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SEMI-AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LIQUID CONTROLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LIQUID CONTROLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LIQUID CONTROLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LYOPHILIZED CONTROLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LYOPHILIZED CONTROLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LYOPHILIZED CONTROLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LIMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LIMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY LIMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COLORIMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COLORIMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY AUTOMATED CELL COUNTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY AUTOMATED CELL COUNTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY AUTOMATED CELL COUNTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIAC MARKER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIAC MARKER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIAC MARKER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BACTERIAL DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BACTERIAL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BACTERIAL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY VIRAL DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY VIRAL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY VIRAL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TUMOR MARKER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TUMOR MARKER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TUMOR MARKER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DRUGS OF ABUSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DRUGS OF ABUSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DRUGS OF ABUSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY NATIONAL BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY NATIONAL BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY NATIONAL BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGIONAL BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGIONAL BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGIONAL BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRIVATE RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 187. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER,

Companies Mentioned

The key companies profiled in this In-Vitro Diagnostics Quality Control market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Grifols, S.A.
  • Microbix Biosystems Inc.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Roche Holding AG
  • Seracare Life Sciences, Inc.
  • Siemens Healthineers AG
  • Sun Diagnostics, LLC
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.
  • ZeptoMetrix LLC

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.74 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.88 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides - Product Image

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

  • Report
  • 372 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030 - Product Image

In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030

  • Report
  • 379 Pages
  • Global
From
In Vitro Diagnostics (Ivd) Quality Control Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

In Vitro Diagnostics (Ivd) Quality Control Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
In Vitro Diagnostics (IVD) Quality Control - Global Strategic Business Report - Product Image

In Vitro Diagnostics (IVD) Quality Control - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.